Explore the complete record of transactions filed by Lunger John, Directeur de l'Approvisionnement des Patients. Officer active across 1 companies, notably Adaptimmune Therapeutics PLC. Cumulatively, 10 filings have been logged. Total volume traded: €87k. The latest transaction was filed on 18 January 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
John Lunger is the Chief Patient Supply Officer at Adaptimmune Therapeutics PLC. He is responsible for managing the supply and logistics of treatments for patients. John plays a key role in optimizing supply chain processes to ensure that patients receive necessary treatments in a timely manner. His expertise in supply chain management is crucial for the success of Adaptimmune's operations.